Close Menu

NEW YORK – Interpace Diagnostics said after the close of the market on Wednesday that its third quarter revenues increased 33 percent year over year.

The Parsippany, New Jersey-based firm also announced that it has changed its name to Interpace Biosciences to better reflect its new business model combining esoteric molecular diagnostic testing with the new drug discovery and development services business it acquired from Cancer Genetics in July.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.